Increased particle flow rate from airways precedes clinical signs of ARDS in a porcine model of LPS-induced acute lung injury
Martin Stenlo, Snejana Hyllén, Iran A N Silva, Deniz A Bölükbas, Leif Pierre, Oskar Hallgren, Darcy E Wagner, Sandra Lindstedt, Martin Stenlo, Snejana Hyllén, Iran A N Silva, Deniz A Bölükbas, Leif Pierre, Oskar Hallgren, Darcy E Wagner, Sandra Lindstedt
Abstract
Acute respiratory distress syndrome (ARDS) is a common cause of death in the intensive care unit, with mortality rates of ~30-40%. To reduce invasive diagnostics such as bronchoalveolar lavage and time-consuming in-hospital transports for imaging diagnostics, we hypothesized that particle flow rate (PFR) pattern from the airways could be an early detection method and contribute to improving diagnostics and optimizing personalized therapies. Porcine models were ventilated mechanically. Lipopolysaccharide (LPS) was administered endotracheally and in the pulmonary artery to induce ARDS. PFR was measured using a customized particles in exhaled air (PExA 2.0) device. In contrast to control animals undergoing mechanical ventilation and receiving saline administration, animals who received LPS developed ARDS according to clinical guidelines and histologic assessment. Plasma levels of TNF-α and IL-6 increased significantly compared with baseline after 120 and 180 min, respectively. On the other hand, the PFR significantly increased and peaked 60 min after LPS administration, i.e., ~30 min before any ARDS stage was observed with other well-established outcome measurements such as hypoxemia, increased inspiratory pressure, and lower tidal volumes or plasma cytokine levels. The present results imply that PFR could be used to detect early biomarkers or as a clinical indicator for the onset of ARDS.
Keywords: ARDS; LPS-induced lung injury; mechanical ventilation; particles in exhaled air.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Figures
References
- Bake B, Larsson P, Ljungkvist G, Ljungström E, Olin AC. Exhaled particles and small airways. Respir Res 20: 8, 2019. doi:10.1186/s12931-019-0970-9.
- Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202: 145–156, 2004. doi:10.1002/path.1491.
- Broberg E, Pierre L, Fakhro M, Algotsson L, Malmsjö M, Hyllén S, Lindstedt S. Different particle flow patterns from the airways after recruitment manoeuvres using volume-controlled or pressure-controlled ventilation. Intensive Care Med Exp 7: 16, 2019. doi:10.1186/s40635-019-0231-8.
- Broberg E, Wlosinska M, Algotsson L, Olin AC, Wagner D, Pierre L, Lindstedt S. A new way of monitoring mechanical ventilation by measurement of particle flow from the airways using Pexa method in vivo and during ex vivo lung perfusion in DCD lung transplantation. Intensive Care Med Exp 6: 18, 2018. doi:10.1186/s40635-018-0188-z.
- Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 319: 698–710, 2018. doi:10.1001/jama.2017.21907.
- Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Definition Task Force . Acute respiratory distress syndrome: the Berlin Definition. JAMA 307: 2526–2533, 2012. doi:10.1001/jama.2012.5669.
- Gonzales JN, Lucas R, Verin AD. The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches. Austin J Vasc Med 2: 1009, 2015.
- Lillehoj EP, Kato K, Lu W, Kim KC. Cellular and molecular biology of airway mucins. Int Rev Cell Mol Biol 303: 139–202, 2013. doi:10.1016/B978-0-12-407697-6.00004-0.
- Liu CH, Kuo SW, Ko WJ, Tsai PR, Wu SW, Lai CH, Wang CH, Chen YS, Chen PL, Liu TT, Huang SC, Jou TS. Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation. Sci Rep 7: 1021, 2017. doi:10.1038/s41598-017-01225-1.
- Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33: 319–327, 2005. doi:10.1165/rcmb.F305.
- Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334–1349, 2000. doi:10.1056/NEJM200005043421806.
- Wyns H, Plessers E, De Backer P, Meyer E, Croubels S. In vivo porcine lipopolysaccharide inflammation models to study immunomodulation of drugs. Vet Immunol Immunopathol 166: 58–69, 2015. doi:10.1016/j.vetimm.2015.06.001.
Source: PubMed